Role of ceramides in skin stress: Ultraviolet light, tape stripping and crowding

Exogenous Dermatology

Volumn 2, Issue 6, 2003, Pages 286-294

  Choi, Myeong Jun ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ceramides; Hydroxyceramides; Overcrowding; Permeability barrier; Physical stress; Tape stripping; Ultraviolet irradiation

Indexed keywords

CERAMIDE; LIPID; SERINE PALMITOYLTRANSFERASE; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; CORRELATION ANALYSIS; DRY SKIN; ENZYME ACTIVITY; KERATINOCYTE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN FUNCTION; SKIN INJURY; STRATUM CORNEUM; STRESS; ULTRAVIOLET RADIATION; WATER PERMEABILITY; WATER RETENTION;

EID: 10644236900     PISSN: 14244616     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081565     Document Type: Review

References (94)

1. Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M: Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 2003;42:1-36.
2. Norlén L, Nicander I, Lundh Rozell B, Ollmar S, Forslind B: Inter- and intraindividual differences in human stratum corneum lipid content related to physical parameters of skin barrier function in vivo. J Invest Dermatol 1999;112:72-77.
3. Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM: The aged epidermal permeability barrier: Structural, functional and lipid biochemical abnormalities in human and a senescent murine model. J Clin Invest 1995;95:2281-2289.
4. Jin K, Higaki Y, Tagaki Y, Higuchi K, Yada Y, Kamashima M, Imokawa G: Analysis of beta-glucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol 1994;74:337-340.
5. Rogers J, Harding C, Mayo A, Banks J, Rawlings A: Stratum corneum lipids: The effect of ageing and the seasons. Arch Dermatol Res 1996;288:765-770.
6. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin. J Invest Dermatol 1991;96:523-526.
7. Pilgram GS, Vissers DC, van der Meulen H, Pavel S, Lavrijsen SP, Bouwstra JA, Koerten HK: Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 2001;117:710-717.
8. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G: High-expression of sphingomyelinase deacylase is an important determinant of ceramide deficiency leading to barrier disruption atopic dermatitis. J Invest Dermatol 2000;115:406-413.
9. Okamoto R, Arikawa J, Ishibashi M, Kawasjima M, Takagi Y, Imokawa G: Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. J Lipid Res 2003;44:93-102.
10. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R: Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1993;1182:147-151.
11. Alessandrini F, Stachowitz S, Ring J, Behrendt H: The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris. J Invest Dermatol 2001;116:394-400.
12. Ponec M, Weerheim A, Lankhorst P, Wertz P: New acylceramide in native and reconstructed epidermis. J Invest Dermatol 2003;120:581-588.
13. Geilen CC, Wieder T, Orfanos CE: Ceramide signaling: Regulatory role in cell proliferation, differentiation and apoptosis in human epidermis. Arch Dermatol Res 1997;289:559-566.
14. Jensen JM, Schutze S, Forl M, Kronke M, Proksch E: Roles for tumor necrosis factor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 1999;104:1761-1770.
15. Proksch E, Holleran WM, Menon GK, Elias PM, Feingold KR: Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol 1993;128:473-482.
16. Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR: Sphingolipids are required for mammalian epidermal barrier function: Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 1991;88:1338-1345.
17. Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E: Consequences of β-glucocerebrosidase deficiency in epidermis: Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994;93:1756-1764.
18. Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM: Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993;91:1656-1664.
19. Berardesca E, Barbareschi M, Veraldi S, Pimpinelli N: Evaluation of efficiency of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: A multicenter study. Contact Dermatitis 2001;45:280-285.
20. Kucharekova M, Schalkwijk J, van de Kerkhof PCM, van de Valk PGM: Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfuction. Contact Dermatitis 2002;46:331-338.
21. Coderch L, De Pera M, Fonollosa J, De La Maza A, Parra J: Efficacy of stratum corneum lipid supplementation on human skin. Contact Dermatitis 2002;47:139-146.
22. Di Nardo A, Sugino K, Wertz P, Ademola J, Maibach HI: Sodium lauryl sulfate (SLS) induced irritant contact dermatitis: A correlation study between ceramides and in vivo parameters of irritation. Contact Dermatitis 1996;35:86-91.
23. Di Nardo A, Sugino K, Ademola J, Wertz P, Maibach HI: Role of ceramides in proclivity to toluene and xylene-induced skin irritation in man. Dermatosen 1996;44:119-125.
24. Burek C, Roth J, Koch HG, Harzer K, Los M, Schulze-Osthoff K: The role of ceramide in receptor and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. Oncogene 2001;20:6493-6502.
25. Pena LA, Fuks Z, Kolesnick R: Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 1997;53:615-621.
26. Claus R, Russwurm S, Meisner M, Kinscherf R, Deigner HD: Modulation of the ceramide level, a novel therapeutic concept? Curr Drug Targets 2000;1:185-205.
27. Donato NJ, Klostergaard J: Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells. Exp Cell Res 2004;294:523-533.
28. Zhao S, Yang YN, Song JG: Ceramide induces caspase-dependent and -independent apoptosis in A-431 cells. J Cell Physiol 2004;199:47-56.
29. Watanabe M, Kitano T, Kondo T, Yabu T, Taguchi Y, Tashima M, Umehara H, Domae N, Uchiyama T, Okazaki T: Increase of nuclear ceramide through caspase-3-dependent regulation of the 'sphingomyelin cycle' in Fas-induced apoptosis. Cancer Res 2004;64:1000-1007.
30. Andriea-Abadie N, Gouaze V, Salvayre R, Levade T: Ceramide in apoptosis signaling: Relationship with oxidative stress. Free Radic Biol Med 2001;31:717-728.
31. Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991;24:1-26.
32. Schurer NY, Elias PM: The biochemistry and function of stratum corneum lipids. Adv Lipid Res 1991;24:27-56.
33. Man MM, Feingold KR, Thornfeldt CR, Elias PM: Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol 1996;106:1096-1101.
34. Chujor CS, Feingold KR, Elias PM, Holleran WM: Glucosylceramide synthase activity in murine epidermis: Quantitation, localization, regulation, and requirement for barrier homeostasis. J Lipid Res 1998;39:277-285.
35. Uchida Y, Murata S, Schmuth M, Behne MJ, Lee JD, Ichikawa S, Elias PM, Hirabayashi Y, Holleran WM: Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress. J Lipid Res 2002; 43:1293-1302.
36. Hanley K, Jiang Y, Holleran WM, Elias PM, Williams ML, Feingold KR: Glucosylceramide metabolism is regulated during normal and hormonally stimulated epidermal barrier development in the rat. J Lipid Res 1997;38:576-584.
37. Sando GN, Howard EJ, Maison KC: Induction of ceramide glucosyltransferase activity in cultured human keratinocytes: Correlation with culture differentiation. J Biol Chem 1996;271:22044-22051.
38. Marsh NL, Elias PM, Holleran WM: Glucosylceramides stimulated murine epidermal hyperproliferation. J Clin Invest 1995;95:2903-2909.
39. Takagi Y, Kriehuber E, Imokawa G, Elias PM, Holleran WM: Beta-glucocerebrosidase activity in mammalian stratum corneum. J Lipid Res 1999;40:861-869.
40. Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold KR, Elias PM: Permeability barrier requirements regulate epidermal beta- glucocerebrosidase. J Lipid Res 1995;35:905-912.
41. Chang F, Swartzendruber DC, Wertz PW, Squier CA: Covalently bound lipids in keratinizing epithelia. Biochim Biophys Acta 1993;1150:98-102.
42. Doering T, Proia RL, Sandhoff K: Accumalation of protein-bound epidermal glucosylceramides in β-glucocerebrosidase de. cient type 2 Gaucher mice. FEBS Lett 1999;447:167-170.
43. Marekov LN, Steinert PM: Ceramides are bound to structural proteins of the human foreskin cornified cell envelope. J Biol Chem 1998;273:17763-17770.
44. Stewart ME, Downing DT: The ω-hydroxyceramides of pig epidermis are attached to corneocytes solely through ω-hydroxy groups. J Lipid Res 2001;42:1105-1110.
45. Behne M, Uchida Y, Seki, T, de Montellano PO, Elias PM, Holleran WM: Omega-hydroxyceramides are required for corneocytes lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 2000;114:185-192.
46. Macheleidt O, Kaiser HW, Sanshoff K: Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002;119:166-173.
47. Denda M: New strategies to improve skin barrier homeostasis. Adv Drug Del Rev 2000;54:s123-s130.
48. Mikulowska A: Reactive changes in human epidermis following simple occlusion with water. Contact Dermatitis 1992;26:224-227.
49. Van den Merwe E, Ackermann C: Physical changes in hydrated skin. Int J Cosmet Sci 1987;9:237-247.
50. Spruit D, Malten KE: The regeneration rate of the water vapor loss of heavily damaged skin. Dermatologica 1966;132:115-123.
51. Choi MJ, Zhai H, Maibach HI: Tape stripping and stratum corneum; in Zhai H, Maibach HI (eds): Dermatoxicology, ed 6. Washington, Taylor & Francis, 2003, pp 531-548.
52. Benfeldt E, Serup J: Effect of barrier perturbation on cutaneous penetration of salicylic acid in hairless rats: In vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Arch Dermatol Res 1999;292:517-526.
53. Benfeldt E, Serup J, Menne T: Effect of barrier perturbation on cutaneous penetration of salicylic acid in human skin: In vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Br J Dermatol 1999;140:739-748.
54. Morgan CJ, Renwick AG, Friedmann PS: The role of stratum corneum and dermal vascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 2003;148:434-443.
55. Regnier V, Tahiri A, Andre N, Lemaitre M, Le Doan T, Preat V: Electroporation-mediated delivery of 3′-protected phosphodiester oligonucleotides to the skin. J Control Release 2000;67:337-346.
56. Choi MJ, Zhai H, Loffler H, Dreher F, Maibach HI: Effect of tape stripping on percutaneous penetration and topical vaccination. Exog Dermatol, in press.
57. Denda M, Hori J, Koyama J, Yoshida S, Nanba R, Takahashi M, Yamamoto A: Stratum corneum sphingolipids and free amino acids in experimentally scaly skin. Arch Dermatol Res 1992;284:598-602.
58. Schmuth M, Man MQ, Weber F, Gao WN, Feingold KR, Fritsch P, Elias PM, Holleran WM: Permeability barrier disorder in Niemann-Pick disease: Sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol 2000;115:459-466.
59. Stachowitz S, Alessandrini F, Abeck D, Ring J, Behrendt H: Permeability barrier disruption increases the level of serine palmitoyltransferase in human epidermis. J Invest Dermatol 2002;119:1048-1052.
60. Harris IR, Farrell AM, Grunfeld C, Holleran WM, Elias PM, Feingold KR: Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J Invest Dermatol 1997;109:783-787.
61. Seville RH: Psoriasis and stress. Br J Dermatol 1977;97:297-302.
62. Seville RH: Psoriasis and stress II. Br J Dermatol 1978;98:151-153.
63. Parkkinen MU, Kistala R, Kistala U: Sweating response to moderate thermal stress in atopic dermatitis. Br J Dermatol 1992;126;346-350.
64. Aioi A, Okuda M, Matsui M, Tonogaito H, Hamada K: Effect of high population density environment on skin barrier function in mice. J Dermatol Sci 2001;25:189-197.
65. Denda M, Tsuchiya T, Hosoi J, Koyama J: Immobilization-induced and crowded environment-induced stress delays barrier recovery in murine skin. Br J Dermatol 1998;138:780-785.
66. Ishida H, Mitsui K, Nukaya H, Matsumoto K, Tsuji K: Study of active substances involved in skin dysfunction induced by crowding stress. I. Effect of crowding and isolation on some physiological variables, skin function and skin blood perfusion in hairless mice. Biol Pharm Bull 2003;26:170-181.
67. Fisher GJ, Datta SC, Talwar HS, Wang ZQ, Varani J, Kang S, Voorhees JJ: Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996;379:335-339.
68. Gilchrest BA, Park HY, Eller MS, Yaar M: Mechanisms of ultraviolet light-induced pigmentation. Photochem Photobiol 1996;63:1-10.
69. Haratake A, Uchida Y, Mimura K, Elias PM, Holleran WM: Intrinsically aged epidermis displays diminished UVB-induced alteration in barrier function associated with decreased proliferation. J Invest Dermatol 1997;108:319-323.
70. Beissert S, Schwarz T: Mechanisms involved in ultraviolet light-induced immunosuppression. J Invest Dermatol Symp Proc 1999;4:61-64.
71. Kraemer KH: Sunlight and skin cancer: Another link revealed. Proc Natl Acad Sci USA 1997;94:11-14.
72. Staberg BL, Wulf HC: The carcinogenic effect of UVA irradiation. J Invest Dermatol 1983;81:517-519.
73. Tyrrell RM, Keyses SM: The interaction of UVA radiation with cultured cells. J Photochem Photobiol B Biol 1990;4:349-361.
74. Bronaugh RL, Stewart RF: Methods for in vitro percutaneous rat absorption studies. V. Penetration through damaged skin. J Pharm Sci 1985;74:1062-1066.
75. Drobetsky EA, Turcotte J, Chateauneuf A: A role of ultraviolet A in solar mutagenesis. Proc Natl Acad Sci USA 1995;92:2350-2354.
76. Kligman LH, Akin FJ, Kligman AM: The contributions of UVA and UVB to connective tissue damage in hairless mice. J Invest Dermatol 1985;84:272-276.
77. Grether-Beck S, Bonizzi G, Schmitt-Brenden H, Felsner I, Timmer A, Sies H, Johnson JP, Piette J, Krutmann J: Non-enzymatic triggering of the ceramide signaling cascade by solar UVA radiation. EMBO J 2000;19:5793-5800.
78. Auge N, Andrieu N, Negre-Salvayre A, Thiers JC, Levade T, Salvayre R: The sphingomyelinceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J Biol Chem 1996;271:19251-19255.
79. Maziere C, Conte MA, Leborgne L, Levade T, Hornebeck W, Santus R, Maziere JC: UVA radiation stimulates ceramide production: Relationship to oxidative stress and potential role in ERK, JNK, and p38 activation. Biochem Biophys Res Commun 2001;281:289-294.
80. Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G: The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 2000;350:747-756.
81. Ishibashi M, Arikawa J, Okamoto R, Kawashima M, Takagi Y, Ohguchi K, Imokawa G: Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis. Lab Invest 2003;83:397-408.
82. Holleran WM, Uchida Y, Halkier-Sorensen L, Haratake A, Hara M, Epstein JH, Elias PM: Structural and biochemical basis for the UVBinduced alterations in epidermal barrier function. Photodermatol Photoimmunol Photomed 1997;13:117-128.
83. Shimizu H, Banno Y, Sumi N, Naganawa T, Kitajima Y, Nozawa Y: Activation of p38 mitogen-activated protein kinase and caspases in UVB-induced apoptosis of human keratinocyte HaCaT cells. J Invest Dermatol 1999;112:769-774.
84. Uchida Y, Di Nardo A, Collins V, Elias PM, Holleran WM: De novo ceramide synthesis participates in the ultraviolet B irradiation-induced apoptosis in undifferentiated cultured human keratinocytes. J Invest Dermatol 2003;120:662-669.
85. Meguro S, Arai Y, Masukawa Y, Uie K, Tokimitsu I: Relationship between covalently bound ceramides and transepidermal water loss (TEWL). Arch Dermatol Res 2000;292:463-468.
86. Farrell AM, Uchida Y, Nagiec MM, Harris IR, Dickson RC, Elias PM, Holleran WM: UVB irradiation up-regulates serine palmitoyltransferase in cultured human keratinocytes. J Lipid Res 1998;39:2031-2038.
87. Haratake A, Uchida Y, Schmuth M, Tanno O, Yasuda R, Epstein JH, Elias PM, Holleran WM: UVB-induced alteration in permeability barrier function: Roles for epidermal hyperproliferation and thymocyte-mediated response. J Invest Dermatol 1997;108:769-775.
88. Magnoni C, Euclidi E, Benassi L, Bertazzoni G, Cossarizzi S, Seidenari S, Giannetti A: Ultraviolet B radiation induces activation of neutral and acid sphingomyelinases and ceramide generation in cultured normal human keratinocytes. Toxicol In Vitro 2002;16:349-355.
89. Meguro S, Arai Y, Masukawa K, Uie K, Tokimitsu I: Stratum corneum lipid abnormalities in UVB-irradiated skin. Photochem Photobiol 1999;69:317-321.
90. Nemes Z, Marekov LN, Fesus L, Steinert PM: A novel function for transglutaminase 1: Attachment of long-chain ω-hydroxyceramides to involucrin by ester bond formation. Proc Natl Acad Sci USA 1999;96:8402-8407.
91. Bernerd F, Asselineau D: Successive alteration and recovery of epidermal differentiation and morphogenesis after specific UVB-damage in skin reconstructed in vitro. Dev Biol 1997;183:123-138.
92. Hedberg CL, Wertz PW, Downing DT: The time course of lipid biosynthesis in pig epidermis. J Invest Dermatol 1988;91:169-174.
93. 2-induced apoptosis with acid sphingomyelinase activation. Biochim Biophys Acta 2001;1533:47-54.
94. Deng J, Zhang H, Kloosterboer F, Liao Y, Klostergaad J, Levitt ML, Hung MC: Ceramide does not act as a general second messenger for ultraviolet-induced apoptosis. Oncogene 2002;21:44-52.